Adar

Serum Institute CEO Adar Poonawalla on Sunday on Twitter asked Elon Musk to invest in India for large-scale manufacturing of Tesla cars, saying it would be the 'best investment' he could ever make. Musk is the CEO of US-based automotive and…

Serum Institute CEOAdar Poonwalla ahs given very special investment advice to Tesla head Elon Musk on Sunday. Poonwalla told Musk that in case he doesn't buy Twitter then he must look at investing some…

After Novak Djokovic stated he would skip the French Open and Wimbledon rather than get vaccinated against Covid-19, Serum Institute of India (SII) chief Adar Poonawalla took to Twitter to say that he hopes the tennis star…

Serum Institute of India CEO Adar Poonawalla on Thursday urged Serbian tennis superstar Novak Djokovic to get vaccinated against COVID-19. The 20-time Grand Slam winner has remained unvaccinated against coronavirus and has maintained that…

As cases of the Omicron variant of coronavirus surge across India, Serum Institute of India (SII) chief Adar Poonawalla shared an interesting post on Twitter. The post is a video clip from the movie…

Adar Poonawalla, the chief executive of vaccine maker Serum Institute of India, has picked up a 20% stake in Wakau Interactive, a subsidiary of digital entertainment and technology company JetSynthesys, for an undisclosed sum. Wakau is a…

<!-- -->Adar Poonawalla has picked up 20 per cent stake in social media platform WakauNew Delhi: Serum Institute of India (SII) chief Adar Poonawalla has picked up a 20 per cent stake in Wakau Interactive, a short-video sharing…

Covovax is under trial and has shown excellent data all the way down to the age group of three years, Mr. Poonawalla said. Serum Institute of India (SII) plans to launch a COVID-19 vaccine for children in the next six months, the…

<!-- -->Adar Poonawalla said Serum Institute of India hopes to launch Covid vaccine for children.The Serum Institute of India (SII) plans to launch the Novavax COVID-19 vaccine for children in the country in six months, its CEO said…

Biocon Biologics Limited (BBL) will offer approximately 15% stake to Serum Institute Life Sciences Private Limited (SILS) at a post-money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annum…